Gts Securities LLC Biotechnology

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
RYTM
Rhythm Pharmaceuticals, Inc.
PUT
$513,000
9.8K
Q2 2024
New holding
VKTX
Viking Therapeutics, Inc.
PUT
$481,000
7.6K N/A
IONS
Ionis Pharmaceuticals Inc
CALL
$480,000
12K
Q3 2024
Reduced 91.7%
MNKD
Mannkind Corp
CALL
$413,000
65.9K
Q2 2024
Added 45.7%
AUPH
Aurinia Pharmaceuticals Inc.
CALL
$403,000
55.1K
Q3 2024
Added 65.49%
FOLD
Amicus Therapeutics, Inc.
CALL
$390,000
36.6K
Q3 2024
Reduced 41.86%
ARDX
Ardelyx, Inc.
PUT
$382,000
55.5K
Q3 2024
Added 17.1%
APLS
Apellis Pharmaceuticals, Inc.
PUT
$337,000
11.7K
Q3 2024
Added 39.29%
KMPH
Kempharm, Inc
CALL
$304,000
61.6K
Q3 2024
Reduced 24.06%
GERN
Geron Corp
PUT
$275,000
60.6K
Q3 2024
Reduced 29.02%
NUVL
Nuvalent, Inc.
PUT
$255,000
2.5K N/A
MRUS
Merus N.V.
PUT
$249,000
5K N/A
INSM
Insmed Inc
PUT
$233,000
3.2K
Q2 2024
New holding
ARDX
Ardelyx, Inc.
CALL
$219,000
31.9K
Q3 2024
Added 17.1%
BMRN
Biomarin Pharmaceutical Inc
CALL
$210,000
3K
Q3 2024
Added 55.0%
EWTX
Edgewise Therapeutics, Inc.
PUT
$208,000
7.8K N/A
APLS
Apellis Pharmaceuticals, Inc.
CALL
$204,000
7.1K
Q3 2024
Added 39.29%
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$195,000
10.1K N/A
ACAD
Acadia Pharmaceuticals Inc
PUT
$189,000
12.3K
Q3 2024
Reduced 45.24%
TERN
Terns Pharmaceuticals, Inc.
PUT
$181,000
21.8K N/A
LQDA
Liquidia Corp
PUT
$160,000
16K
Q3 2024
Added 3.1%
GERN
Geron Corp
CALL
$156,000
34.5K
Q3 2024
Reduced 29.02%
IOVA
Iovance Biotherapeutics, Inc.
CALL
$145,000
15.5K
Q1 2024
Reduced 56.48%
HUMA
Humacyte, Inc.
CALL
$114,000
21.1K N/A
OCGN
Ocugen, Inc.
CALL
$92,000
93.1K
Q3 2024
Reduced 38.64%
TERN
Terns Pharmaceuticals, Inc.
CALL
$92,000
11.1K N/A
ABUS
Arbutus Biopharma Corp
CALL
$81,000
21.2K
Q3 2024
New holding
AMLX
Amylyx Pharmaceuticals, Inc.
PUT
$79,000
24.4K
Q1 2024
Added 11.75%
RVNC
Revance Therapeutics, Inc.
CALL
$72,000
28.2K
Q2 2024
Reduced 72.49%
EDIT
Editas Medicine, Inc.
CALL
$70,000
20.6K
Q3 2024
Reduced 35.21%
SANA
Sana Biotechnology, Inc.
PUT
$61,000
14.7K
Q3 2024
New holding
BDTX
Black Diamond Therapeutics, Inc.
PUT
$56,000
13K N/A
ABUS
Arbutus Biopharma Corp
PUT
$46,000
12.1K
Q3 2024
New holding
ABCL
Ab Cellera Biologics Inc.
CALL
$45,000
17.4K
Q3 2024
Added 17.02%
SGMO
Sangamo Therapeutics, Inc
PUT
$44,000
51.4K
Q4 2023
Reduced 44.57%
OCGN
Ocugen, Inc.
PUT
$30,000
30.7K
Q3 2024
Reduced 38.64%
SGMO
Sangamo Therapeutics, Inc
CALL
$29,000
34.6K
Q4 2023
Reduced 44.57%
AKBA
Akebia Therapeutics, Inc.
CALL
$21,000
16.5K
Q3 2024
New holding
ALXO
Alx Oncology Holdings Inc
CALL
$18,000
10K N/A
CMRX
Chimerix Inc
CALL
$17,000
18.8K
Q2 2024
New holding
BLUE
Bluebird Bio, Inc.
PUT
$16,000
32.5K
Q3 2024
Reduced 74.06%
BLUE
Bluebird Bio, Inc.
CALL
$14,000
27K
Q3 2024
Reduced 74.06%
KPTI
Karyopharm Therapeutics Inc.
CALL
$9,000
11.1K N/A
Filter Shares Options
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email